A small portion of patients with hepatitis B major yang can develop into liver cancer, but this development process is generally long. Primary liver cancer is currently the fourth most common malignant tumor in China, and the third leading cause of tumor death, seriously threatening the lives and health of our people. Primary liver cancer includes three types, of which hepatocellular carcinoma accounts for more than 85% to 90%. A large part of patients with primary liver cancer in China, most of whom have a background of chronic hepatitis B and cirrhosis.